Arixtra 7.5mg Injection
By Arixtra
Rx
0ml Injection in a Vial

Composition
Fondaparinux(7.5mg)

Manufacturer - Glaxo SmithKline Pharmaceuticals Ltd
Dr. Annie Besant Road, Mumbai - 400 030

Expires on or after
August, 2025
About Arixtra 7.5mg Injection
Arixtra 7.5mg Injection is a medication classified as an anticoagulant, which means it helps prevent the formation of harmful blood clots in the blood vessels. It is primarily used to treat conditions such as deep vein thrombosis, a clot in the veins of the leg, and pulmonary embolism, a clot in the artery of the lungs.
This injection is especially beneficial for individuals who have undergone knee or hip replacement surgeries, or those who have been confined to bed for an extended period. It is vital to administer Arixtra 7.5mg Injection under the close supervision of a healthcare provider who will determine the appropriate dosage and duration for each patient.
However, it's important to note that using this medication may elevate the risk of bleeding. If you observe symptoms such as pinpoint rash or notice blood in your vomit, urine, or stool, it's crucial to inform your doctor immediately. Before starting treatment with Arixtra 7.5mg Injection, it is essential to disclose any pre-existing conditions such as bleeding disorders, kidney or liver diseases to your healthcare provider. Additionally, inform your doctor if you are pregnant, breastfeeding, or taking any other medications regularly.
It is recommended to continue all other prescribed medications for your long-term treatment even after receiving the Arixtra 7.5mg Injection to ensure comprehensive care. Adhering to your doctor's instructions and communicating openly about your health status and any potential side effects will help optimize the effectiveness of this medication and minimize risks.
Benefits
Arixtra 7.5mg Injection provides significant benefits for individuals dealing with conditions like deep vein thrombosis and pulmonary embolism. In cases of deep vein thrombosis, which involves the formation of blood clots in deep veins, this medication plays a crucial role in preventing these clots from developing. By doing so, Arixtra 7.5mg Injection ensures that blood can flow freely throughout the body, reducing the risks of serious complications such as heart attacks or strokes. Moreover, it not only stops the formation of new blood clots but also hinders existing ones from growing larger. To enhance the drug's effectiveness, incorporating positive lifestyle changes like maintaining a healthy diet and staying physically active is recommended.
Similarly, for individuals at risk of pulmonary embolism, where blood clots form in the lungs, Arixtra 7.5mg Injection proves to be a valuable preventative measure. By inhibiting the clot formation in the lungs, this medication facilitates unobstructed blood flow, lowering the chances of cardiovascular events like heart attacks or strokes. Just like in deep vein thrombosis, Arixtra 7.5mg Injection works to halt the growth of existing blood clots in the lungs as well. To optimize the benefits of this drug, it is crucial to adhere closely to the guidance provided by your healthcare provider.
In conclusion, Arixtra 7.5mg Injection is a vital medication that not only combats the formation of blood clots in critical areas of the body but also safeguards against the enlargement of existing clots. By incorporating healthy lifestyle habits alongside this treatment, individuals can further amplify the positive impacts of this medicine in preventing life-threatening conditions associated with deep vein thrombosis and pulmonary embolism.
How to use the Arixtra 7.5mg Injection
When it comes to using Arixtra 7.5mg Injection, it's important to remember that you should always have a healthcare professional such as your doctor or nurse administer this medication. Do not attempt to administer it yourself. The injection is given either under the skin, in a skin fold of the lower abdominal area, or directly into a vein. Your doctor will determine the appropriate dosage and duration of treatment based on factors like your age, body weight, and specific medical condition. Trust your healthcare provider to guide you through the proper use of Arixtra 7.5mg Injection to ensure safe and effective treatment.
Uses of Arixtra 7.5mg Injection
Arixtra 7.5mg Injection is used in adults for treating conditions like deep vein thrombosis, pulmonary embolism, certain types of heart attack, and severe angina caused by narrowed arteries. It is also beneficial for blood clots in superficial veins of the legs, as well as blood vessels in the legs or lungs post orthopedic or abdominal surgery. Additionally, this injection is administered during and right after a period of restricted movement due to acute illness.
What conditions Arixtra 7.5mg Injection treats?
Arixtra 7.5mg Injection is used for treating deep vein thrombosis, which is a condition where a clot forms in a vein deep inside the body. It also helps in pulmonary embolism, where a clot forms in the lungs. By preventing these clots, the medicine ensures smooth blood flow, reducing the risk of heart attack or stroke. Lifestyle changes like a healthy diet and staying active can enhance its effectiveness. It's vital to comply with your doctor's guidance, especially if you've had knee or hip surgery or prolonged bed rest, while being mindful of potential side effects such as bleeding.
Should you consult a doctor?
Before deciding to receive Fondazest 7.5mg Injection, it is important to consult a doctor if you have conditions such as excessive bleeding, stomach ulcers, bleeding disorders, recent intracranial bleeding, or recent surgery on the brain, spine, or eye. If you experience any of these situations or have a history of them, seeking medical advice before using Fondazest 7.5mg Injection is crucial. It is vital to prioritize your health and safety by discussing your medical history with a healthcare professional to determine if Fondazest 7.5mg Injection is suitable for you.
Side effects of Arixtra 7.5mg Injection
When taking Arixtra 7.5mg Injection, some common side effects you may experience include bleeding, anemia (low red blood cell count), swelling (edema), and nausea or vomiting. Other possible side effects are reduced red blood cell count (anemia), chest pain, breathlessness, rash or itchy skin, fever, and oozing from the operation wound site. You might also notice bleeding from a surgical site or existing stomach ulcer, nosebleeds, bruising, and allergic reactions such as itching, swelling, or rash. Headache, drowsiness, flushing, coughing, wound infections, and internal bleeding in the brain, liver, or abdomen are other potential side effects. Some individuals may experience dizziness, fainting, low blood pressure, pain and swelling at the injection site, and changes in blood platelet levels and non-protein nitrogen amounts. Stomach or leg pain, indigestion, diarrhea or constipation, increased bilirubin levels in the blood, anxiety or confusion, and reduced potassium levels are also possible side effects. It's essential to stop using Arixtra 7.5mg Injection and contact your doctor immediately if you develop severe allergic reactions like anaphylaxis, which can present as swelling of the face or mouth (angioedema) leading to difficulty in swallowing or breathing, or if you experience collapse. Remember that most side effects tend to resolve as your body adjusts to the medication, but if they persist or you have concerns, consult your doctor for guidance.
Safety advice

liver
When using Arixtra 7.5mg Injection, it is important to be cautious if you have severe liver disease. Patients with this condition may require a dose adjustment for Arixtra 7.5mg Injection. It is advised to consult your doctor before using this medication to ensure it is safe for your liver health.

kidney
Arixtra 7.5mg Injection should be used carefully in patients with kidney disease. Adjusting the dosage may be necessary. Avoid using in severe kidney disease. Consult your doctor before using Arixtra 7.5mg Injection.

alcohol
It is not safe to drink alcohol while taking Arixtra 7.5mg Injection.

driving
It is not clear if Arixtra 7.5mg Injection affects driving ability. Avoid driving if you have symptoms that impact focus and reaction time.

pregnancy
Arixtra 7.5mg Injection is usually safe to use in pregnancy. Animal studies suggest minimal harm to the baby, but human data is limited.

breastfeeding
Arixtra 7.5mg Injection is considered safe for breastfeeding mothers as per limited data available. The drug does not seem to pose a significant risk to the baby.
Age above 75(Geriatrics)
Age below 6 months(Pediatrics)
Consumption warning before consuming Arixtra 7.5mg Injection
Before taking Arixtra 7.5mg Injection, it is important to be aware of certain warnings. This medication is used to treat conditions like deep vein thrombosis and pulmonary embolism by preventing the formation of harmful blood clots in the blood vessels. It is also helpful for individuals who have undergone knee or hip replacement surgeries or those who have been bedridden for long periods.
It is crucial to remember that Arixtra 7.5mg Injection can increase the risk of bleeding. If you notice symptoms like pinpoint rash, blood in vomit, urine, or stool, inform your doctor immediately. Prior to starting this medication, discuss any bleeding disorders, kidney or liver diseases with your doctor. Additionally, disclose if you are pregnant, breastfeeding, or taking other medications regularly.
Always follow your doctor's instructions regarding the dose and duration of Arixtra 7.5mg Injection. Even while on this treatment, continue taking all other medications prescribed for your long-term care. Remember, this medication should only be administered under the supervision of a healthcare professional.
What if you forgot to take Arixtra 7.5mg Injection?
If you realize you’ve missed a dose of Arixtra 7.5mg Injection, try to take it as soon as you remember. But if it's nearly time for your next scheduled dose, it’s best to skip the missed one and continue with your normal dosing routine. Avoid taking a double dose to make up for the missed one. It's important to stick to the recommended dosing schedule for the medication to work effectively.
What happens if you take overdose of Arixtra 7.5mg Injection?
Arixtra 7.5mg Injection is a medication that should only be given by a medical professional in a hospital setting, reducing the risk of an overdose. However, it is essential to be aware of any unusual symptoms and promptly inform your doctor or nurse. This proactive approach ensures early detection and management of any potential overdose situations. Regular communication with healthcare providers can help address any concerns and ensure the safe and effective use of Arixtra 7.5mg Injection to maintain your well-being.
Related lab tests
When assessing a patient receiving Arixtra 7.5mg Injection, it is important to consider certain related lab tests to monitor their health and response to treatment. These tests include the Activated Partial Thromboplastin Time (APTT), Platelet Count, and Prothrombin Time.
The Activated Partial Thromboplastin Time (APTT) test measures how long it takes for the blood to clot. It is crucial in evaluating the function of certain clotting factors and is used to monitor patients on anticoagulant therapy, such as Arixtra 7.5mg Injection.
Platelet Count is another important lab test that measures the number of platelets in the blood. Platelets are small cell fragments that help in blood clotting. Monitoring the platelet count is essential as Arixtra 7.5mg Injection may affect platelet function and increase the risk of bleeding or clotting disorders.
Prothrombin Time is a test that evaluates the ability of the blood to clot properly. It measures the time it takes for the blood to clot after certain clotting factors are added. This test is valuable in monitoring the effectiveness of Arixtra 7.5mg Injection and assessing the risk of bleeding complications.
Regular monitoring of these related lab tests can help healthcare providers ensure the safety and efficacy of treatment with Arixtra 7.5mg Injection.
Additional Information
Habit Forming | No |
Chemical Class | Synthetic Glucopyranoside |
Therapeutic Class | CARDIAC |
Action Class | Selective inhibitor of activated Factor X |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹1320
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024